JP2004518111A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518111A5
JP2004518111A5 JP2002537170A JP2002537170A JP2004518111A5 JP 2004518111 A5 JP2004518111 A5 JP 2004518111A5 JP 2002537170 A JP2002537170 A JP 2002537170A JP 2002537170 A JP2002537170 A JP 2002537170A JP 2004518111 A5 JP2004518111 A5 JP 2004518111A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002537170A
Other versions
JP2004518111A (ja
JP4068454B2 (ja
Filing date
Publication date
Priority claimed from US09/697,934 external-priority patent/US6743596B1/en
Application filed filed Critical
Publication of JP2004518111A publication Critical patent/JP2004518111A/ja
Publication of JP2004518111A5 publication Critical patent/JP2004518111A5/ja
Application granted granted Critical
Publication of JP4068454B2 publication Critical patent/JP4068454B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002537170A 2000-10-27 2001-10-18 包括的な凝固性および止血能を判定するための方法 Expired - Fee Related JP4068454B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/697,934 US6743596B1 (en) 2000-10-27 2000-10-27 Method of determining global coagulability hemostatic potential
PCT/US2001/032564 WO2002034110A2 (en) 2000-10-27 2001-10-18 Method of determining global coagulability and hemostatic potential

Publications (3)

Publication Number Publication Date
JP2004518111A JP2004518111A (ja) 2004-06-17
JP2004518111A5 true JP2004518111A5 (ja) 2007-07-26
JP4068454B2 JP4068454B2 (ja) 2008-03-26

Family

ID=24803183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002537170A Expired - Fee Related JP4068454B2 (ja) 2000-10-27 2001-10-18 包括的な凝固性および止血能を判定するための方法

Country Status (8)

Country Link
US (2) US6743596B1 (ja)
EP (1) EP1337660A4 (ja)
JP (1) JP4068454B2 (ja)
AU (2) AU1461902A (ja)
BR (1) BR0114936A (ja)
CA (1) CA2427231A1 (ja)
MX (1) MXPA03003682A (ja)
WO (1) WO2002034110A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162361T3 (es) * 1998-03-19 2001-12-16 Instrumentation Lab Spa Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea.
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US7282368B2 (en) 2002-02-27 2007-10-16 Biomerieux, Inc. Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
ES2524444T3 (es) * 2002-06-27 2014-12-09 Roberto Beretta Método para preparar una lámina de fibrina sólida
DE102005008066A1 (de) * 2005-02-22 2006-08-24 Haemosys Gmbh Verfahren zur Bestimmung der Gesamtgerinnungsaktivität einer Blut- oder Plasmaprobe
WO2007004466A1 (ja) * 2005-07-01 2007-01-11 Sysmex Corporation 分析装置
EP1909105A1 (en) * 2006-10-06 2008-04-09 Royal College of Surgeons in Ireland A method of determining platelet function
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
CA2757961C (en) 2009-04-09 2020-02-04 Entegrion, Inc. Spray-dried blood products and methods of making same
WO2011075614A2 (en) * 2009-12-18 2011-06-23 Entegrion, Inc. Portable coagulation monitoring device and method of assessing coagulation response
US10739358B2 (en) 2009-12-18 2020-08-11 Entegrion, Inc. Portable coagulation monitoring devices, systems, and methods
US20140242707A1 (en) * 2011-07-21 2014-08-28 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine Compositions and Methods for Diagnosing Hypercoagulability and Hypocoagulability
WO2013028759A1 (en) * 2011-08-22 2013-02-28 The General Hospital Corporation Assessing coagulation
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
CN107209192B (zh) 2014-12-18 2019-06-11 皇家飞利浦有限公司 用于确定血液样本中的纤维蛋白原水平的装置、系统和方法
JP6430809B2 (ja) * 2014-12-19 2018-11-28 公立大学法人奈良県立医科大学 血液検体を判定するための方法、システム及びコンピュータプログラム、並びに血液検体分析装置
JP6871673B2 (ja) * 2015-03-31 2021-05-12 学校法人東日本学園 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置
JP6952668B2 (ja) * 2018-09-28 2021-10-20 シスメックス株式会社 血液凝固分析方法、血液凝固分析装置、プログラム
JPWO2022145477A1 (ja) * 2020-12-28 2022-07-07
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US5472850A (en) * 1991-04-10 1995-12-05 Oklahoma Medical Research Foundation Quantitative clotting assay for activated factor VII
NL8902406A (nl) 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.
US5646046A (en) * 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
DK0565665T3 (da) 1991-10-04 1998-09-28 Dade Behring Inc Fremstilling af prothrombin-tidsreagenser ud fra rekombinant human faktor og syntetiske phospholipider
DE4133946A1 (de) 1991-10-14 1993-04-15 Behringwerke Ag Funktioneller test und reagenz zur bestimmung von fibrinogen
SE470274B (sv) 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
DE608235T1 (de) * 1991-11-13 1994-12-22 Bjoern Dahlbaeck Vefahren zur diagnose von störungen der blutgerinnung.
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
DE4427785A1 (de) 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
ES2154703T5 (es) 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) * 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6124110A (en) * 1997-04-09 2000-09-26 Drk-Blutspendedienst Nordrheinwestfalen Ggmbh Method for determining activated coagulation factors in plasma and plasma derivatives
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
US6245573B1 (en) 1998-02-12 2001-06-12 University Of Medicine And Dentistry Of New Jersey Rapid assessment of the coagulant activity of blood
ES2162361T3 (es) * 1998-03-19 2001-12-16 Instrumentation Lab Spa Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea.
WO1999064622A1 (en) * 1998-06-08 1999-12-16 University Of Vermont And State Agriculture College Inhibition of coagulation in blood and blood products
AU774889B2 (en) * 1999-02-04 2004-07-08 Biomerieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
JP2003505678A (ja) * 1999-07-23 2003-02-12 ザ スクリップス リサーチ インスティテュート 全血の凝固因子活性を測定する方法
US6645768B1 (en) * 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C502I2 (ja)
BE2022C547I2 (ja)
BE2017C057I2 (ja)
BE2017C051I2 (ja)
BE2017C032I2 (ja)
BE2016C051I2 (ja)
BE2015C046I2 (ja)
BE2014C052I2 (ja)
BE2014C036I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2014C006I2 (ja)
BE2017C050I2 (ja)
JP2001314413A5 (ja)
JP2001292155A5 (ja)
JP2001355704A5 (ja)
BRPI0209186B1 (ja)
JP2002151523A5 (ja)
BE2014C008I2 (ja)
BRPI0204884B1 (ja)
CH1379220H1 (ja)
BE2016C021I2 (ja)
BE2017C059I2 (ja)
BRPI0101486B8 (ja)